Calcium-ATPases: Gene disorders and dysregulation in cancer

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 6, 2016, Pages 1344-1350

  Dang, Donna ^a   Rao, Rajini ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Calcium ATPase; Calcium signaling; Golgi; Lactation; Secretory pathway

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCO EDNDOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SECRETORY PATHWAY CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ATP2A2 GENE; ATP2C1 GENE; AUTOSOMAL DOMINANT DISORDER; BREAST CANCER; CALCIUM HOMEOSTASIS; COLON CANCER; DEVELOPMENTAL DISORDER; ENDOPLASMIC RETICULUM; GENE; GENE MUTATION; GENETIC DISORDER; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MUSCLE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SECRETORY PATHWAY; ANIMAL; GENETIC PREDISPOSITION; GENETICS; HOMEOSTASIS; METABOLISM; MUTATION; NEOPLASM;

ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; ENDOPLASMIC RETICULUM; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; MUTATION; NEOPLASMS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84964277262     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.11.016     Document Type: Review

References (101)

1. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
2. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
3. Brini M., Carafoli E. Calcium signalling: a historical account, recent developments and future perspectives. Cell. Mol. Life Sci. 2000, 57:354-370.
4. Mooren F.C., Kinne R.K. Cellular calcium in health and disease. Biochim. Biophys. Acta 1998, 1406:127-151.
5. Orrenius S., Gogvadze V., Zhivotovsky B. Calcium and mitochondria in the regulation of cell death. Biochem. Biophys. Res. Commun. 2015, 460:72-81.
6. Palmgren M.G., Nissen P. P-type ATPases. Annu. Rev. Biophys. 2011, 40:243-266.
7. Palmgren M.G., Axelsen K.B. Evolution of P-type ATPases. Biochim. Biophys. Acta 1998, 1365:37-45.
8. Kuhlbrandt W. Biology, structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell Biol. 2004, 5:282-295.
9. Vangheluwe P., Sepulveda M.R., Missiaen L., Raeymaekers L., Wuytack F., Vanoevelen J. Intracellular Ca2+- and Mn2+- transport ATPases. Chem. Rev. 2009, 109:4733-4759.
10. Brini M., Cali T., Ottolini D., Carafoli E. Calcium pumps: why so many?. Compr. Physiol. 2012, 2:1045-1060.
11. McFarland B.H., Inesi G. Solubilization of sarcoplasmic reticulum with Triton X-100. Arch. Biochem. Biophys. 1971, 145:456-464.
12. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 2005, 85:201-279.
13. Bergner A., Huber R.M. Regulation of the endoplasmic reticulum Ca(2+)-store in cancer. Anti Cancer Agents Med. Chem. 2008, 8:705-709.
14. Periasamy M., Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 2007, 35:430-442.
15. Zhao Y., Ogawa H., Yonekura S., Mitsuhashi H., Mitsuhashi S., Nishino I., Toyoshima C., Ishiura S. Functional analysis of SERCA1b, a highly expressed SERCA1 variant in myotonic dystrophy type 1 muscle. Biochim. Biophys. Acta 2015, 1852:2042-2047.
16. Vangheluwe P., Raeymaekers L., Dode L., Wuytack F. Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 2005, 38:291-302.
17. Baba-Aissa F., Raeymaekers L., Wuytack F., Dode L., Casteels R. Distribution and isoform diversity of the organellar Ca2+ pumps in the brain. Mol. Chem. Neuropathol. 1998, 33:199-208.
18. Martin V., Bredoux R., Corvazier E., Van Gorp R., Kovacs T., Gelebart P., Enouf J. Three novel sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 3 isoforms. Expression, regulation, and function of the membranes of the SERCA3 family. J. Biol. Chem. 2002, 277:24442-24452.
19. Dode L., De Greef C., Mountian I., Attard M., Town M.M., Casteels R., Wuytack F. Structure of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene. Promoter analysis and alternative splicing of the SERCA3 pre-mRNA. J. Biol. Chem. 1998, 273:13982-13994.
20. Toyoshima C., Cornelius F. New crystal structures of PII-type ATPases: excitement continues. Curr. Opin. Struct. Biol. 2013, 23:507-514.
21. Toyoshima C., Mizutani T. Crystal structure of the calcium pump with a bound ATP analogue. Nature 2004, 430:529-535.
22. Olesen C., Picard M., Winther A.M., Gyrup C., Morth J.P., Oxvig C., Moller J.V., Nissen P. The structural basis of calcium transport by the calcium pump. Nature 2007, 450:1036-1042.
23. Krebs J. The plethora of PMCA isoforms: alternative splicing and differential expression. Biochim. Biophys. Acta 2015, 1853:2018-2024.
24. Chicka M.C., Strehler E.E. Alternative splicing of the first intracellular loop of plasma membrane Ca2 + -ATPase isoform 2 alters its membrane targeting. J. Biol. Chem. 2003, 278:18464-18470.
25. Strehler E.E. Plasma membrane calcium ATPases: from generic Ca(2+) sump pumps to versatile systems for fine-tuning cellular Ca(2.). Biochem. Biophys. Res. Commun. 2015, 460:26-33.
26. Reinhardt T.A., Lippolis J.D., Shull G.E., Horst R.L. Null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2 impairs calcium transport into milk. J. Biol. Chem. 2004, 279:42369-42373.
27. Burette A., Weinberg R.J. Perisynaptic organization of plasma membrane calcium pumps in cerebellar cortex. J. Comp. Neurol. 2007, 500:1127-1135.
28. Rudolph H.K., Antebi A., Fink G.R., Buckley C.M., Dorman T.E., LeVitre J., Davidow L.S., Mao J.I., Moir D.T. The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family. Cell 1989, 58:133-145.
29. Sorin A., Rosas G., Rao R. PMR1, a Ca2+-ATPase in yeast Golgi, has properties distinct from sarco/endoplasmic reticulum and plasma membrane calcium pumps. J. Biol. Chem. 1997, 272:9895-9901.
30. Durr G., Strayle J., Plemper R., Elbs S., Klee S.K., Catty P., Wolf D.H., Rudolph H.K. The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol. Biol. Cell 1998, 9:1149-1162.
31. Yadav J., Muend S., Zhang Y., Rao R. A phenomics approach in yeast links proton and calcium pump function in the Golgi. Mol. Biol. Cell 2007, 18:1480-1489.
32. Ton V.K., Rao R. Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases. Am. J. Physiol. Cell Physiol. 2004, 287:C580-C589.
33. Pestov N.B., Dmitriev R.I., Kostina M.B., Korneenko T.V., Shakhparonov M.I., Modyanov N.N. Structural evolution and tissue-specific expression of tetrapod-specific second isoform of secretory pathway Ca2+-ATPase. Biochem. Biophys. Res. Commun. 2012, 417:1298-1303.
34. Vanoevelen J., Dode L., Van Baelen K., Fairclough R.J., Missiaen L., Raeymaekers L., Wuytack F. The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions. J. Biol. Chem. 2005, 280:22800-22808.
35. Fairclough R.J., Dode L., Vanoevelen J., Andersen J.P., Missiaen L., Raeymaekers L., Wuytack F., Hovnanian A. Effect of Hailey-Hailey disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1). J. Biol. Chem. 2003, 278:24721-24730.
36. Dode L., Andersen J.P., Vanoevelen J., Raeymaekers L., Missiaen L., Vilsen B., Wuytack F. Dissection of the functional differences between human secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and 2 isoenzymes by steady-state and transient kinetic analyses. J. Biol. Chem. 2006, 281:3182-3189.
37. Xiang M., Mohamalawari D., Rao R. A novel isoform of the secretory pathway Ca2+, Mn(2+)-ATPase, hSPCA2, has unusual properties and is expressed in the brain. J. Biol. Chem. 2005, 280:11608-11614.
38. Garside V.C., Kowalik A.S., Johnson C.L., DiRenzo D., Konieczny S.F., Pin C.L. MIST1 regulates the pancreatic acinar cell expression of Atp2c2, the gene encoding secretory pathway calcium ATPase 2. Exp. Cell Res. 2010, 316:2859-2870.
39. Feng M., Grice D.M., Faddy H.M., Nguyen N., Leitch S., Wang Y., Muend S., Kenny P.A., Sukumar S., Roberts-Thomson S.J., Monteith G.R., Rao R. Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell 2010, 143:84-98.
40. Kunzelmann K., Mehta A. CFTR: a hub for kinases and crosstalk of cAMP and Ca2+. FEBS J. 2013, 280:4417-4429.
41. Proks P., de Wet H., Ashcroft F.M. Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study. J. Gen. Physiol. 2014, 144:469-486.
42. Neville M.C. Calcium secretion into milk. J. Mammary Gland Biol. Neoplasia 2005, 10:119-128.
43. Cross B.M., Breitwieser G.E., Reinhardt T.A., Rao R. Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology. Am. J. Physiol. Cell Physiol. 2014, 306:C515-C526.
44. Cross B.M., Hack A., Reinhardt T.A., Rao R. SPCA2 regulates Orai1 trafficking and store independent Ca2+ entry in a model of lactation. PLoS One 2013, 8.
45. Reinhardt T.A., Horst R.L. Ca2+-ATPases and their expression in the mammary gland of pregnant and lactating rats. Am. J. Physiol. 1999, 276:C796-C802.
46. Reinhardt T.A., Lippolis J.D. Mammary gland involution is associated with rapid down regulation of major mammary Ca2+-ATPases. Biochem. Biophys. Res. Commun. 2009, 378:99-102.
47. Davis F.M., Janoshazi A., Janardhan K.S., Steinckwich N., D'Agostin D.M., Petranka J.G., Desai P.N., Roberts-Thomson S.J., Bird G.S., Tucker D.K., Fenton S.E., Feske S., Monteith G.R., Putney J.W. Essential role of Orai1 store-operated calcium channels in lactation. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:5827-5832.
48. Okunade G.W., Miller M.L., Pyne G.J., Sutliff R.L., O'Connor K.T., Neumann J.C., Andringa A., Miller D.A., Prasad V., Doetschman T., Paul R.J., Shull G.E. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J. Biol. Chem. 2004, 279:33742-33750.
49. Kobayashi Y., Hirawa N., Tabara Y., Muraoka H., Fujita M., Miyazaki N., Fujiwara A., Ichikawa Y., Yamamoto Y., Ichihara N., Saka S., Wakui H., Yoshida S., Yatsu K., Toya Y., Yasuda G., Kohara K., Kita Y., Takei K., Goshima Y., Ishikawa Y., Ueshima H., Miki T., Umemura S. Mice lacking hypertension candidate gene ATP2B1 in vascular smooth muscle cells show significant blood pressure elevation. Hypertension 2012, 59:854-860.
50. Lu X., Wang L., Chen S., He L., Yang X., Shi Y., Cheng J., Zhang L., Gu C.C., Huang J., Wu T., Ma Y., Li J., Cao J., Chen J., Ge D., Fan Z., Li Y., Zhao L., Li H., Zhou X., Chen L., Liu D., Chen J., Duan X., Hao Y., Wang L., Lu F., Liu Z., Yao C., Shen C., Pu X., Yu L., Fang X., Xu L., Mu J., Wu X., Zheng R., Wu N., Zhao Q., Li Y., Liu X., Wang M., Yu D., Hu D., Ji X., Guo D., Sun D., Wang Q., Yang Y., Liu F., Mao Q., Liang X., Ji J., Chen P., Mo X., Li D., Chai G., Tang Y., Li X., Du Z., Liu X., Dou C., Yang Z., Meng Q., Wang D., Wang R., Yang J., Schunkert H., Samani N.J., Kathiresan S., Reilly M.P., Erdmann J., Coronary A.D.G.-W.R., Meta-Analysis C., Peng X., Wu X., Liu D., Yang Y., Chen R., Qiang B., Gu D. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 2012, 44:890-894.
51. Bortolozzi M., Brini M., Parkinson N., Crispino G., Scimemi P., De Siati R.D., Di Leva F., Parker A., Ortolano S., Arslan E., Brown S.D., Carafoli E., Mammano F. The novel PMCA2 pump mutation Tommy impairs cytosolic calcium clearance in hair cells and links to deafness in mice. J. Biol. Chem. 2010, 285:37693-37703.
52. Kozel P.J., Friedman R.A., Erway L.C., Yamoah E.N., Liu L.H., Riddle T., Duffy J.J., Doetschman T., Miller M.L., Cardell E.L., Shull G.E. Balance and hearing deficits in mice with a null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2. J. Biol. Chem. 1998, 273:18693-18696.
53. Spiden S.L., Bortolozzi M., Di Leva F., de Angelis M.H., Fuchs H., Lim D., Ortolano S., Ingham N.J., Brini M., Carafoli E., Mammano F., Steel K.P. The novel mouse mutation oblivion inactivates the PMCA2 pump and causes progressive hearing loss. PLoS Genet. 2008, 4.
54. Inoue Y., Matsumura Y., Inoue K., Ichikawa R., Takayama C. Abnormal synaptic architecture in the cerebellar cortex of a new dystonic mutant mouse, Wriggle Mouse Sagami. Neurosci. Res. 1993, 16:39-48.
55. Prasad V., Okunade G.W., Miller M.L., Shull G.E. Phenotypes of SERCA and PMCA knockout mice. Biochem. Biophys. Res. Commun. 2004, 322:1192-1203.
56. Brody I.A. Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. N. Engl. J. Med. 1969, 281:187-192.
57. Benders A.A., Veerkamp J.H., Oosterhof A., Jongen P.J., Bindels R.J., Smit L.M., Busch H.F., Wevers R.A. Ca2+ homeostasis in Brody's disease. A study in skeletal muscle and cultured muscle cells and the effects of dantrolene an verapamil. J. Clin. Invest. 1994, 94:741-748.
58. Odermatt A., Barton K., Khanna V.K., Mathieu J., Escolar D., Kuntzer T., Karpati G., MacLennan D.H. The mutation of Pro789 to Leu reduces the activity of the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA1) and is associated with Brody disease. Hum. Genet. 2000, 106:482-491.
59. Odermatt A., Taschner P.E., Khanna V.K., Busch H.F., Karpati G., Jablecki C.K., Breuning M.H., MacLennan D.H. Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease. Nat. Genet. 1996, 14:191-194.
60. Pan Y., Zvaritch E., Tupling A.R., Rice W.J., de Leon S., Rudnicki M., McKerlie C., Banwell B.L., MacLennan D.H. Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice. J. Biol. Chem. 2003, 278:13367-13375.
61. Brini M., Carafoli E. Calcium pumps in health and disease. Physiol. Rev. 2009, 89:1341-1378.
62. Burge S.M., Wilkinson J.D. Darier-White disease: a review of the clinical features in 163 patients. J. Am. Acad. Dermatol. 1992, 27:40-50.
63. Foggia L., Aronchik I., Aberg K., Brown B., Hovnanian A., Mauro T.M. Activity of the hSPCA1 Golgi Ca2+ pump is essential for Ca2+-mediated Ca2+ response and cell viability in Darier disease. J. Cell Sci. 2006, 119:671-679.
64. Dhitavat J., Cobbold C., Leslie N., Burge S., Hovnanian A. Impaired trafficking of the desmoplakins in cultured Darier's disease keratinocytes. J. Invest. Dermatol. 2003, 121:1349-1355.
65. Prasad V., Lorenz J.N., Lasko V.M., Nieman M.L., Huang W., Wang Y., Wieczorek D.W., Shull G.E. SERCA2 haploinsufficiency in a mouse model of Darier disease causes a selective predisposition to heart failure. Biomed. Res. Int. 2015, 2015:251598.
66. Varadi A., Lebel L., Hashim Y., Mehta Z., Ashcroft S.J., Turner R. Sequence variants of the sarco(endo)plasmic reticulum Ca(2+)-transport ATPase 3 gene (SERCA3) in Caucasian type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 1999, 42:1240-1243.
67. Hu Z., Bonifas J.M., Beech J., Bench G., Shigihara T., Ogawa H., Ikeda S., Mauro T., Epstein E.H. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat. Genet. 2000, 24:61-65.
68. Sudbrak R., Brown J., Dobson-Stone C., Carter S., Ramser J., White J., Healy E., Dissanayake M., Larregue M., Perrussel M., Lehrach H., Munro C.S., Strachan T., Burge S., Hovnanian A., Monaco A.P. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum. Mol. Genet. 2000, 9:1131-1140.
69. Ton V.K., Rao R. Expression of Hailey-Hailey disease mutations in yeast. J. Invest. Dermatol. 2004, 123:1192-1194.
70. Dhitavat J., Fairclough R.J., Hovnanian A., Burge S.M. Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease. Br. J. Dermatol. 2004, 150:821-828.
71. Okunade G.W., Miller M.L., Azhar M., Andringa A., Sanford L.P., Doetschman T., Prasad V., Shull G.E. Loss of the Atp2c1 secretory pathway Ca(2+)-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J. Biol. Chem. 2007, 282:26517-26527.
72. Smith A.W., Holden K.R., Dwivedi A., Dupont B.R., Lyons M.J. Deletion of 16q24.1 supports a role for the ATP2C2 gene in specific language impairment. J. Child Neurol. 2015, 30:517-521.
73. Newbury D.F., Winchester L., Addis L., Paracchini S., Buckingham L.L., Clark A., Cohen W., Cowie H., Dworzynski K., Everitt A., Goodyer I.M., Hennessy E., Kindley A.D., Miller L.L., Nasir J., O'Hare A., Shaw D., Simkin Z., Simonoff E., Slonims V., Watson J., Ragoussis J., Fisher S.E., Seckl J.R., Helms P.J., Bolton P.F., Pickles A., Conti-Ramsden G., Baird G., Bishop D.V., Monaco A.P. CMIP and ATP2C2 modulate phonological short-term memory in language impairment. Am. J. Hum. Genet. 2009, 85:264-272.
74. Stewart T.A., Yapa K.T., Monteith G.R. Altered calcium signaling in cancer cells. Biochim. Biophys. Acta 2015, 1848:2502-2511.
75. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
76. Burnside E.S., Ochsner J.E., Fowler K.J., Fine J.P., Salkowski L.R., Rubin D.L., Sisney G.A. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology 2007, 242:388-395.
77. Cox R.F., Morgan M.P. Microcalcifications in breast cancer: lessons from physiological mineralization. Bone 2013, 53:437-450.
78. Morgan M.P., Cooke M.M., McCarthy G.M. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors?. J. Mammary Gland Biol. Neoplasia 2005, 10:181-187.
79. James A.D., Patel W., Butt Z., Adiamah M., Dakhel R., Latif A., Uggenti C., Swanton E., Imamura H., Siriwardena A.K., Bruce J.I. The plasma membrane calcium pump in pancreatic cancer cells exhibiting the Warburg effect relies on glycolytic ATP. J. Biol. Chem. 2015, 290:24760-24771.
80. Reinhardt T.A., Filoteo A.G., Penniston J.T., Horst R.L. Ca(2+)-ATPase protein expression in mammary tissue. Am. J. Physiol. Cell Physiol. 2000, 279:C1595-C1602.
81. Lee W.J., Roberts-Thomson S.J., Monteith G.R. Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. Biochem. Biophys. Res. Commun. 2005, 337:779-783.
82. Ribiczey P., Tordai A., Andrikovics H., Filoteo A.G., Penniston J.T., Enouf J., Enyedi A., Papp B., Kovacs T. Isoform-specific up-regulation of plasma membrane Ca2+ ATPase expression during colon and gastric cancer cell differentiation. Cell Calcium 2007, 42:590-605.
83. Aung C.S., Kruger W.A., Poronnik P., Roberts-Thomson S.J., Monteith G.R. Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation. Biochem. Biophys. Res. Commun. 2007, 355:932-936.
84. Saito K., Uzawa K., Endo Y., Kato Y., Nakashima D., Ogawara K., Shiba M., Bukawa H., Yokoe H., Tanzawa H. Plasma membrane Ca2+ ATPase isoform 1 down-regulated in human oral cancer. Oncol. Rep. 2006, 15:49-55.
85. Roti G., Carlton A., Ross K.N., Markstein M., Pajcini K., Su A.H., Perrimon N., Pear W.S., Kung A.L., Blacklow S.C., Aster J.C., Stegmaier K. Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. Cancer Cell 2013, 23:390-405.
86. Brouland J.P., Gelebart P., Kovacs T., Enouf J., Grossmann J., Papp B. The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. Am. J. Pathol. 2005, 167:233-242.
87. Gelebart P., Kovacs T., Brouland J.P., van Gorp R., Grossmann J., Rivard N., Panis Y., Martin V., Bredoux R., Enouf J., Papp B. Expression of endomembrane calcium pumps in colon and gastric cancer cells. Induction of SERCA3 expression during differentiation. J. Biol. Chem. 2002, 277:26310-26320.
88. Launay S., Gianni M., Kovacs T., Bredoux R., Bruel A., Gelebart P., Zassadowski F., Chomienne C., Enouf J., Papp B. Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood 1999, 93:4395-4405.
89. Ait-Ghezali L., Arbabian A., Jeibmann A., Hasselblatt M., Hallaert G.G., Van den Broecke C., Gray F., Brouland J.P., Varin-Blank N., Papp B. Loss of endoplasmic reticulum calcium pump expression in choroid plexus tumours. Neuropathol. Appl. Neurobiol. 2014, 40:726-735.
90. Dellis O., Arbabian A., Brouland J.P., Kovacs T., Rowe M., Chomienne C., Joab I., Papp B. Modulation of B-cell endoplasmic reticulum calcium homeostasis by epstein-barr virus latent membrane protein-1. Mol. Cancer 2009, 8:59.
91. Fan L., Li A., Li W., Cai P., Yang B., Zhang M., Gu Y., Shu Y., Sun Y., Shen Y., Wu X., Hu G., Xu Q. Novel role of sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog. Biomed. Pharmacother. 2014, 68:1141-1148.
92. Liu L.H., Boivin G.P., Prasad V., Periasamy M., Shull G.E. Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump. J. Biol. Chem. 2001, 276:26737-26740.
93. Grice D.M., Vetter I., Faddy H.M., Kenny P.A., Roberts-Thomson S.J., Monteith G.R. Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J. Biol. Chem. 2010, 285:37458-37466.
94. Prevarskaya N., Skryma R., Shuba Y. Targeting Ca(2)(+) transport in cancer: close reality or long perspective?. Expert Opin. Ther. Targets 2013, 17:225-241.
95. Doan N.T., Paulsen E.S., Sehgal P., Moller J.V., Nissen P., Denmeade S.R., Isaacs J.T., Dionne C.A., Christensen S.B. Targeting thapsigargin towards tumors. Steroids 2015, 97:2-7.
96. Schonthal A.H. Targeting endoplasmic reticulum stress for cancer therapy. Front. Biosci. (Schol. Ed.) 2012, 4:412-431.
97. GenSpera, Efficacy, safety and CNS exposure of G-202 in patients with recurrent or progressive glioblastoma, ClinicalTrials.gov, (2015).
98. Denmeade S.R., Mhaka A.M., Rosen D.M., Brennen W.N., Dalrymple S., Dach I., Olesen C., Gurel B., Demarzo A.M., Wilding G., Carducci M.A., Dionne C.A., Moller J.V., Nissen P., Christensen S.B., Isaacs J.T. Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci. Transl. Med. 2012, 4:140-186.
99. Kohn K.W., Zeeberg B.M., Reinhold W.C., Pommier Y. Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype. PLoS One 2014, 9.
100. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
101. Clark M.A., Fisher C., Judson I., Thomas J.M. Soft-tissue sarcomas in adults. N. Engl. J. Med. 2005, 353:701-711.